On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Hemptown USA

Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum feminized hemp grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company’s “soil to oil” methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon’s famed Emerald Triangle, Kentucky and Colorado.

Hemptown has rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.

In 2018, Hemptown’s harvest from its Oregon hemp farm was 110,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue is expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demand and projects it will reap over 1 million pounds. By 2020, Hemptown projects that potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.

Growth Strategy

By 2020, Hemptown anticipates it will have more than 2,500 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Due to its anticipated scale, Hemptown is positioning itself as a low-cost producer as it establishes business-to-business partners in the packaged goods space. New products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown’s growth strategy.

Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.

Branded Products

Hemptown’s first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company’s original hemp farm in the Siskiyou Klamath region of Oregon. Siskū is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.

Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown’s product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.

Management Team

Company Chairman Rod Wolterman founded Hemptown’s Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.

CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent’s first GMP and ISO-accredited cultivation and manufacturing facility.

Dr. Gordon Chiu is chief science officer for Hemptown. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master’s degree from Seton Hall University, Chiu is leading Hemptown’s cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.

Investment Considerations
  • Superior genetics program with strains high in CBG, CBD and other high-potential cannabinoids
  • 1 million rare CBG seeds for the 2019 growing season and beyond
  • Biomass producing higher yields with up to 20% full-spectrum CBD and other cannabinoids
  • Multistate farming presence in Oregon, Colorado and Kentucky projected to cultivate 2,500 acres by 2020
  • Sales and distribution channels include contract wholesale, bulk wholesale, in-house brands and white labeled products
  • Disruptive product formulation ensures water solubility, high bioavailability and efficacy
  • U.S. hemp-derived CBD sales forecast calls for $22 billion by 2022
Additional Resources

LinkedIn Instagram

Company News & Data

News & Media Overview Chart Financials Filings Time & Sales Historical Data

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722